Clinical Trials on Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
Total 1004 results
-
HiberCell, Inc.Completed
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
RenJi HospitalRecruitingBreast Cancer | Prostate Cancer | Non Small Cell Lung CancerChina
-
Fondazione Ricerca TraslazionaleUnknownNon Small Cell Lung Cancer | Metastatic Cancer | Advanced CancerItaly
-
PfizerCompletedTrial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell Lung (NSCLC)Ukraine, Poland, Romania, South Africa
-
A2 Biotherapeutics Inc.Tempus AIRecruitingCancer | Colorectal Neoplasms | Colorectal Cancer | Pancreatic Neoplasms | Pancreatic Cancer | NSCLC | Solid Tumor | Non Small Cell Lung Cancer | Colorectal Cancer Metastatic | Pancreas Cancer | Colorectal Adenocarcinoma | Solid Tumor, Adult | CRC | NSCLC, Recurrent | Non Small Cell Lung Cancer Recurrent | Non-Small Cell...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | Metastatic Head and Neck... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Centre René GauducheauCompletedSmall Cell Lung Cancer | CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)France
-
Charu AggarwalLoxo Oncology, Inc.RecruitingNon Small Cell Lung Cancer Metastatic | Non-Squamous Non-Small Cell Neoplasm of Lung | Newly Diagnosed NSCLCUnited States
-
Yuhan CorporationThe Korean Academy of Tuberculosis and Respiratory DiseasesRecruiting
-
Peking University Cancer Hospital & InstituteGeneplus-Beijing Co. Ltd.Recruiting
-
Hunan Province Tumor HospitalNot yet recruiting
-
Shanghai Chest HospitalShanghai Junshi Bioscience Co., Ltd.Recruiting
-
Oslo University HospitalSt. Olavs HospitalRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Kura Oncology, Inc.Withdrawn
-
Qian ChuCompleted
-
Hutchison Medipharma LimitedCompleted
-
Betta Pharmaceuticals Co., Ltd.Unknown
-
Shanghai Chest HospitalUnknown
-
GlobeImmuneMemorial Sloan Kettering Cancer CenterCompleted
-
Sheba Medical CenterUnknown
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Kunming Medical UniversityRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorChina
-
Universitaire Ziekenhuizen KU LeuvenRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorBelgium
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
Hoffmann-La RocheWithdrawn
-
Genentech, Inc.Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPoland, Belgium, Spain, United States, Canada, South Africa, Russian Federation, Hong Kong, Taiwan, Japan, France, United Kingdom, Australia, Germany, Hungary, Korea, Republic of, Netherlands, Croatia, Serbia, Israel, Ukraine, Peru, Brazi... and more
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Syndax PharmaceuticalsCompletedBreast Cancer | Lung Cancer | Non Small Cell Lung Cancer (NSCLC) | Estrogen Receptor Breast CancerUnited States
-
National University Hospital, SingaporeUnknownPatients With Non-small Cell Lung CancerSingapore
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
Fudan UniversityUnknown
-
Shandong Provincial HospitalUnknown
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
University Hospital, BrestActive, not recruitingNon-small Cell Lung Cancer | Lung Metastasis | SBRTFrance
-
National Cancer Center, ChinaNot yet recruiting
-
Henan Provincial People's HospitalNot yet recruiting
-
Tang-Du HospitalNot yet recruiting
-
University Hospital, BrestCompleted
-
Affiliated Hospital of North Sichuan Medical CollegeJiangsu HengRui Medicine Co., Ltd.Unknown
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Terminated
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of